HPH-15

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

HPH-15 is an antifibrotic drug with higher AMPK-activation activity than metformin. The cellular target of this compound is still being investigated, but binding and knockout studies suggest that it is heterogeneous nuclear ribonucleoprotein U. By binding to this nuclear ribonucleoprotein the expression of many proteins can be affected indirectly, by changing mRNA processing.

HPH-15 is an antifibrotic drug with higher AMPK-activation activity than metformin. The cellular target of this compound is still being investigated, but binding and knockout studies suggest that it is heterogeneous nuclear ribonucleoprotein U. By binding to this nuclear ribonucleoprotein the expression of many proteins can be affected indirectly, by changing mRNA processing.

References

Text derived from https://en.wikipedia.org/w/index.php?oldid=1315336445 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

1 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.